JPWO2022059767A1 - - Google Patents

Info

Publication number
JPWO2022059767A1
JPWO2022059767A1 JP2022550624A JP2022550624A JPWO2022059767A1 JP WO2022059767 A1 JPWO2022059767 A1 JP WO2022059767A1 JP 2022550624 A JP2022550624 A JP 2022550624A JP 2022550624 A JP2022550624 A JP 2022550624A JP WO2022059767 A1 JPWO2022059767 A1 JP WO2022059767A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550624A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022059767A1 publication Critical patent/JPWO2022059767A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022550624A 2020-09-17 2021-09-17 Pending JPWO2022059767A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020156458 2020-09-17
PCT/JP2021/034243 WO2022059767A1 (ja) 2020-09-17 2021-09-17 オートファジー活性化剤

Publications (1)

Publication Number Publication Date
JPWO2022059767A1 true JPWO2022059767A1 (https=) 2022-03-24

Family

ID=80776075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550624A Pending JPWO2022059767A1 (https=) 2020-09-17 2021-09-17

Country Status (5)

Country Link
JP (1) JPWO2022059767A1 (https=)
KR (1) KR20230051262A (https=)
CN (1) CN116507314A (https=)
TW (1) TWI844795B (https=)
WO (1) WO2022059767A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006515872A (ja) * 2003-01-17 2006-06-08 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗増殖性質を有する化合物
WO2020090881A1 (ja) * 2018-11-02 2020-05-07 昭和電工株式会社 水中油滴型皮膚外用剤
JP2020141567A (ja) * 2019-03-04 2020-09-10 公立大学法人横浜市立大学 精子形成誘導用培地
JP2021098668A (ja) * 2019-12-23 2021-07-01 株式会社アイ・ティー・オー 細胞送達用キャリア

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003900200A0 (en) * 2003-01-17 2003-01-30 Vital Health Sciences Pty Ltd Compounds having antiproliferative properties
WO2013018779A1 (ja) 2011-08-01 2013-02-07 株式会社林原 α-グルコシルヘスペリジンの結晶とその用途
KR20170141705A (ko) 2015-04-08 2017-12-26 바이오멘딕스, 엘엘씨 상처 치유를 조절하기 위한 제형 및 방법
JP6740354B2 (ja) 2015-10-05 2020-08-12 ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク オートファジーの流れ及びホスホリパーゼd及びタウを含むタンパク質凝集体のクリアランスの活性化剤ならびにタンパク質症の治療方法
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006515872A (ja) * 2003-01-17 2006-06-08 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗増殖性質を有する化合物
WO2020090881A1 (ja) * 2018-11-02 2020-05-07 昭和電工株式会社 水中油滴型皮膚外用剤
JP2020141567A (ja) * 2019-03-04 2020-09-10 公立大学法人横浜市立大学 精子形成誘導用培地
JP2021098668A (ja) * 2019-12-23 2021-07-01 株式会社アイ・ティー・オー 細胞送達用キャリア

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BEHL CHRISTIAN ET AL.: "Vitamin E Protects Nerve Cells from Amyloid β Protein Toxicity", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 186, no. 2, JPN6021042925, 1992, pages 944 - 950, ISSN: 0005759833 *
GUGLIANDOLO AGNESE ET AL.: "α-Tocopherol Modulates Non-Amyloidogenic Pathway and Autophagy in an In Vitro Model of Alzheimer's", BRAIN SCI, vol. 9, no. 196, JPN6021042928, 10 August 2019 (2019-08-10), pages 1 - 16, ISSN: 0005759832 *

Also Published As

Publication number Publication date
WO2022059767A1 (ja) 2022-03-24
KR20230051262A (ko) 2023-04-17
CN116507314A (zh) 2023-07-28
TWI844795B (zh) 2024-06-11
TW202228715A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
JPWO2022059763A1 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260219